Address: jl. Senen Raya 135 Graha Atrium lt 16 jakarta 10410,Indonesia
Tel: + 62 021 3441330
Anugerah Corporation is a diversified holding company with its primary businesses in the pharmaceutical industry. Founded by Dr. Willem Wanandi in 1983 after he returned from chairing the WHO’s ‘Drug Action Plan’(DAP) in Geneva. The first business was PT Anugerah Pharmindo Lestari (APL) on the distribution side of the business. Combiphar, a generics manufacturer, was acquired in 1985. Tigaka Distrindo Perkasa (TDP) was then acquired in 1997 to expand the business into raw materials importing. Anugerah Corporation holds between 20-30 companies, including a number of smaller pharmaceutical service providers such as Pahala Bumi Pertiwi, Farmindo, Pharma Serve, Pharma Health Care, C2, Crush, SCH, BP, and AIL. Anugerah Corporation now holds a minority stake in APL, having sold 70% of the company to Zuellig in 2005. The group has 2500 employees across its various business, with Combiphar by far the largest at over 1000 employees. Combiphar has 15 OTC products and 122 Ethical drugs. They are seeking to incorporate nanotechnology as a key component of their new products, having launched Pronemia, a nano-iron supplement, in 2008.
The development of the Local Pharmaceutical industry companies has gone through rough times, competing from the very beginning with MNCs and going through the economic shock in the 90’s. In…
Rahardjo Jamtomo is the executive director of Kadin Indonesia, the Indonesian Chamber of Commerce and Industry that has seen its role increasing in recent years. As the Chamber has been…
Dr. Agus Prabowo, chairman at LKPP (the Indonesian National Public Procurement Agency) explains the importance of embracing technology to gain efficiency and effectiveness in the public procurement process of healthcare…
Dr. Hasbullah Thabrany, chairman at the Center for Social Security Studies Universitas Indonesia (CSSUI) and Senior Health Care Financing Consultant to the National Social Security Council of Indonesia, explains the…
Dr. Sigit Priohutomo, chairman of DJSN (National Social Security Council of Indonesia), explains DJSN’s action plan to implement the SJSN (Indonesian Social Security System), meant to offer basic social security…
Alban Nérot, managing director at Servier Indonesia, explains the transformational change of the Indonesian affiliate to ensure the sustainable growth of its business in the country as well as the…
Chris Wren, Executive Director of BritCham for the last ten years, explains the changes that have happened on the Indonesian market as well as opportunities for foreign companies to invest…
Parulian Simanjuntak, Executive Director at IPMG, explains the crucial role that MNCs should play within Indonesian universal healthcare coverage (JKN) and discusses the future challenges that should be addressed to…
Steve Yang, Chief Executive Officer of Metiska Farma, talks about the changes he implemented to the comopany once he took over for his father in 2009 and what it means…
Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote medical communities, and why changing the mindset from ‘guinea…
Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote medical communities, and why changing the mindset from ‘guinea…
The CEO of independent distributor Anugerah Pharmindo Lestari (APL) discusses the current market trends in Indonesia for distribution, which involve local pharma companies keeping their distribution in-house, and how his company,…
The CEO of Metiska Farma talks about coming back to Indonesia after studying in the US at Berkeley and MIT, to take over the company, and the company’s strategy of…
See our Cookie Privacy Policy Here
